AXIM Biotechnologies, Inc. announced that it has entered into a securities purchase agreement with Catalina Valencia for a private placement of 3,861,004 restricted shares at a price of $0.0259 per share for gross proceeds of $100,000.0036 on August 24, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0099 USD | +14.65% |
|
+32.00% | -47.89% |
1st Jan change | Capi. | |
---|---|---|
-47.89% | 2.92M | |
+19.41% | 45.51B | |
-8.62% | 38.52B | |
+38.65% | 38.13B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |
- Stock Market
- Equities
- AXIM Stock
- News AXIM Biotechnologies, Inc.
- AXIM Biotechnologies, Inc. announced that it expects to receive $0.1 million in funding